NCT03112382View on ClinicalTrials.gov

Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

zinc supplement plus vitamin A and E

DRUG

vitamin A and E

Trial Locations (1)

Unknown

theoutpatient clinics, department of internal medicine, Cairo University teaching hospitals,, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03112382 - Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter